Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jim Manzi
AddedMar 31, 2024
UpdatedJun 28, 2026
Jim Manzi

Jim Manzi

Board Member, Thermo Fisher th

Crunchbase

Jim Manzi's Career

Thermo Fisher th
Thermo Fisher th

Waltham, MA, US

Board Member· Board
Skyword
Skyword

Boston, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jim Manzi's Career

Thermo Fisher th
Thermo Fisher th
Public$119B130k2006Waltham, MA, US
Board Member· Board

Leadership at Thermo Fisher th

Martin HarrisMartin HarrisBoard Member
Dion WeislerDion WeislerBoard Member
Ruby ChandyRuby ChandyBoard Member
Tyler JacksTyler JacksBoard Member
Lars Rebien SørensenLars Rebien SørensenBoard Member
Scott SperlingScott SperlingBoard Member

Similar to Thermo Fisher th

Portal BiotechnologiesPortal BiotechnologiesWatertown, MA, USest. 2023Portal BiotechnologiesWatertown, MA, US · est. 2023

Portal Biotechnologies is a Watertown, Massachusetts-based cell engineering and drug discovery platform company founded in 2023.

Series A · $9M
Bio-RadBio-RadHercules, CA, USDiagnostics, Life Scienceest. 1952Bio-RadHercules, CA, US · est. 1952

Bio-Rad Laboratories: A leading biotech firm specializing in life science research, clinical diagnostics, and analytical instrumentation.

Public · $1.2B8k
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
RevvityRevvityWaltham, MA, USLife Science Researchest. 1937RevvityWaltham, MA, US · est. 1937

PerkinElmer: A global leader in diagnostics, life science research, and industrial testing, operating in 190 countries.

Public16.7k
Skyword
Skyword
Private Equity$71.5M2042010Boston, MA, US
Board Member· Board

Leadership at Skyword

Mark RoehrenbeckMark RoehrenbeckBoard Member
George BitarGeorge BitarBoard Member
Doug McCormickDoug McCormickBoard Member
Tom GeraceTom GeraceFounder
Andrew WheelerAndrew WheelerCEO
Peggy ByrdPeggy ByrdBoard Member

Similar to Skyword

MarketMuseMarketMuseBoston, MA, USContent Strategyest. 2013MarketMuseBoston, MA, US · est. 2013

MarketMuse: Accelerating content research with AI-driven strategy solutions.

Series A · $9.2M22
Rock ContentRock ContentBoca Raton, FL, USContent Marketing, Softwareest. 2013Rock ContentBoca Raton, FL, US · est. 2013

Florida-based Rock Content: Global leader in strategizing business-generating content marketing.

Series B · $34M778
ContentlyContentlyNew York City, NY, USContent Marketing, Softwareest. 2010ContentlyNew York City, NY, US · est. 2010

Top-rated content marketing solution offering expert strategy, enterprise platform, and global creator network.

Series C · $19.4M200
CloudwordsCloudwordsSan Francisco, CA, USTranslation Managementest. 2010CloudwordsSan Francisco, CA, US · est. 2010

American software firm, Cloudwords, accelerates global campaigns with robust project management tools.

Series B · $14.4M25

Jim Manzi's Co-Investors

Matt MullenwegMatt MullenwegCo-invested · Elysium Health Series BRobert NelsenRobert NelsenCo-invested · Elysium Health Series BNick MacShaneNick MacShaneCo-invested · Gather Series EShane NemanShane NemanCo-invested · Elysium Health Series CJack ConnorsJack ConnorsCo-invested · Gather Series DAndrew TobiasAndrew TobiasCo-invested · Gather Series AJon LovelaceJon LovelaceCo-invested · Gather Series AJon LovelaceJon LovelaceCo-invested · Gather Series A

Jim Manzi's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Jim Manzi

Marc CasperMarc CasperBoard Member · Thermo Fisher thSuzanne Nora JohnsonSuzanne Nora JohnsonBoard Member · University of Southern CaliforniaJohn RiceJohn RiceBoard Member · Baker HughesPaula A. PricePaula A. PriceBoard Member · AccentureMarcy KlevornMarcy KlevornBoard Member · Northern TrustLorence KimLorence KimCo-Founder · Ascenta Capital